Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swizzle Ventures is an early-stage venture capital firm founded in 2023 by Jessica Kamada. The firm focuses on investing in women-led startups that advance women's health, caregiving solutions, and financial equity. Its inaugural fund closed at $6.6 million in early 2025—more than double its initial target—and has already backed at least 11 companies with plans to invest in up to 30 from Fund I. The fund typically invests $100,000–$200,000 per company at the pre-seed or seed stage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swizzle Ventures.